5 ML galsulfase 1 MG/ML Injection [Naglazyme]
RxNorm concept 584222, branded drug (sbd). Prescribable name: Naglazyme 5 MG in 5 ML Injection.
- RxCUI
- 584222
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/584222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
5 ML Naglazyme 1 MG/ML Injection; Naglazyme 5 MG per 5 ML Injection
Related concepts
- galsulfase 1 MG/ML (SCDC, consists of)
- galsulfase 1 MG/ML [Naglazyme] (SBDC, consists of)
- Injection (DF, has dose form)
- Naglazyme (BN, has ingredient)
- 5 ML galsulfase 1 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 584222 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/584222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 584222. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.